Alvotech

ALVO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.79-8.01%

2026-08-03

Financials

Valuation Metrics

Alvotech's Market Cap is $1.18B. At end of 2025 it was $1.43B. Ranked #2410 of 3,112 in US market (top 77%), #969 of 1,445 on NASDAQ (top 67%), #181 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 67%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.18B	US#2,410/3,112 Sec#181/269
Revenue	$559M	US#2,297/3,112 Sec#76/269
Net Income	$-81M	US—/3,112 Sec—/269
Total Assets	$1.42B	US#2,268/3,112 Sec#70/269
Net Assets	$228M	US#2,692/3,112 Sec#188/269
Value
P/B	5.18x	US#2,205/3,112 Sec#144/269
P/S	2.11x	US#1,316/3,112 Sec#33/269
EV/EBITDA	49.71x	US#2,355/3,112 Sec#79/269
FCF Yield	-17.80%	US—/3,112 Sec—/269
Profitability
ROE	-35.38%	US#2,658/3,112 Sec#138/269
ROA	-5.68%	US#2,551/3,112 Sec#95/269
Op. Margin	13.80%	US#1,311/3,112 Sec#52/269
Revenue Growth	-20.26%	US#2,780/3,112 Sec#153/269
Earnings Growth	-99.06%	US#2,062/3,112 Sec#64/269
Financial Health
Debt Ratio	746.46%	US#2,584/3,112 Sec#238/269
Total Debt	$1.46B	US#1,290/3,112 Sec#33/269
FCF	$-210M	US#2,740/3,112 Sec#220/269
Cash	$64M	US#2,470/3,112 Sec#211/269
Current Ratio	1.76x	US#1,430/3,112 Sec#237/269
Net Debt/EBITDA	26.89x	US#2,487/3,112 Sec#92/269
Performance
1Y Return	-56.88%	US#3,022/3,112 Sec#255/269
1M Return	4.99%	US#958/3,112 Sec#40/269
From 52W High	-59.03%	US#2,928/3,112 Sec#239/269
1Y MDD	-72.84%	US#2,958/3,112 Sec#248/269
Trading
Volume	1,023,905 shares	US#1,446/3,112 Sec#143/269
Trading Value	$4M	US#2,744/3,112 Sec#226/269
Per Share
EPS	$0.10	US#2,026/3,112 Sec#72/269